Skip to main content
Figure 2 | BMC Infectious Diseases

Figure 2

From: Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa

Figure 2

Comparative survival of animals with acute pyelonephritis by multidrug-resistant Pseudomonas aeruginosa and administration of therapy upon presentation of signs of sepsis. A: controls, B: clarithromycin, C: amikacin, D: both agents. p of comparisons between groups: A vs D 0.049; C vs D 0.045; A vs C NS (non-significant); and A vs B NS

Back to article page